Finance Watch: A One-Time Treatment For Heart Disease? Verve Raises $58.5m To Give It A Try

 
• By Mandy Jackson
  
Finance Watch
Verve will use gene editing to prevent coronary heart disease.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business